American Distilling Inc. – FDA 483, Apr 26, 2022
An FDA inspection of American Distilling Inc., an OTC drug manufacturer in East Hampton, CT, revealed significant deficiencies across multiple areas. The firm failed to adhere to its written stability testing program and lacked adequate release testing for finished products, including microbiological testing. Additionally, the inspection found that written procedures for equipment cleaning and maintenance were not established or followed, and the quality control unit did not consistently perform timely reviews of facility records.
ID · c0f48efb-2730-4ea1-a006-06e6106d796a
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.